NASDAQ: EVGN
Evogene Ltd Stock Ownership - Who owns Evogene?

Insider buying vs selling

Have Evogene Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVGN insiders and whales buy or sell their stock.

EVGN Shareholders

What type of owners hold Evogene Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Citadel Advisors LLC0.66%57,575$58.73kInstitution
Jane Street Group LLC0.45%39,423$40.21kInstitution
Morgan Stanley0.35%30,343$30.95kInstitution
Two Sigma Securities LLC0.13%11,406$11.63kInstitution
Bnp Paribas Financial Markets0.13%11,231$11.46kInstitution
Ubs Group Ag0.01%1,201$1.23kInstitution
Altshuler Shaham Ltd0.01%750$765.00Institution
Sbi Securities Co Ltd0.01%669$682.38Institution
Steward Partners Investment Advisory LLC0.01%505$515.10Institution
Federation Des Caisses Desjardins Du Quebec0.01%500$510.00Institution

1 of 2

EVGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVGN1.77%0.00%
ICU7.68%92.32%Net BuyingNet Buying
EDSA23.93%76.07%
BIVI2.45%97.55%
INAB4.74%95.26%Net BuyingNet Buying

Evogene Stock Ownership FAQ

Who owns Evogene?

Evogene (NASDAQ: EVGN) is owned by 1.77% institutional shareholders, 0.00% Evogene insiders, and 98.23% retail investors. Citadel Advisors LLC is the largest individual Evogene shareholder, owning 57,575.00 shares representing 0.66% of the company. Citadel Advisors LLC's Evogene shares are currently valued at $54.41k.

If you're new to stock investing, here's how to buy Evogene stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.